obesity

Overview

Obesity is a chronic, progressive disease characterized by excess adiposity that adversely affects health. Clinically, it is commonly defined using body mass index (BMI), with obesity typically corresponding to BMI ≥30 kg/m², although body-fat distribution and obesity-related complications are increasingly recognized as important for risk stratification. Obesity is associated with insulin resistance, low-grade systemic inflammation, dyslipidemia, hypertension, type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD), cardiovascular disease, heart failure, sleep apnea, infertility, and several pregnancy-related complications.

Biologically, obesity reflects a complex interaction among genetic susceptibility, epigenetic regulation, diet, physical activity, endocrine signaling, gut microbiota, and adipose tissue dysfunction. Recent research has emphasized pathways involving GLP-1 receptor signaling, GIP/GLP-1 co-agonism, Leptin (LEP) and Adiponectin (APN) biology, AMPK/TBK1, NF-κB, toll like receptor 4 (TLR4)/MyD88, and other metabolic and inflammatory circuits. Because obesity influences multiple organ systems, it is both a disease entity in its own right and a major modifier of outcomes across surgery, transplantation, cardiometabolic disease, reproductive health, and cancer.

Recent Publications Summary

Recent studies have evaluated the real-world effectiveness of pharmacological interventions for obesity management. A retrospective analysis of 630,545 UK patients initiating tirzepatide via a digital prescribing service documented mean weight loss of −13.5% at 6 months and −17.4% at 12 months, with 89.9% achieving at least 5% weight loss within the first 6 months 42560020Aug. A randomized controlled trial examined 9-mg mazdutide, a glucagon and glucagon-like peptide-1 receptor dual agonist, in Chinese adults, measuring percentage body weight change and achievement of at least 5% weight reduction as coprimary outcomes over 60 weeks of treatment 42251595Jun.

Obesity status has been examined as a significant comorbidity affecting perioperative and surgical outcomes across multiple procedures and clinical populations. Studies using national surgical databases assessed body mass index as a predictor of surgical complexity and outcomes in adolescents undergoing posterior fossa decompression for Chiari malformation 42498796Jul, in adults receiving single-port robot-assisted pyeloplasty 42324413Jun, and in patients undergoing robotic partial nephrectomy 42319664Jun. In obstetrics, prepregnancy obesity emerged as a major risk factor for preeclampsia and eclampsia, with substantial variation in this association by race and ethnicity, particularly affecting Black, Hispanic, and American Indian/Alaska Native populations 42294754Jun.

Obesity's associations with cardiovascular and metabolic disease have been investigated across diverse populations and contexts. Among patients with moderate-to-severe coronary artery calcification, obesity was analyzed as a cardiovascular-kidney-metabolic risk factor using machine learning models to predict adverse clinical outcomes 42462211Jul. Cross-sectional studies from NHANES and All of Us cohorts demonstrated that associations between socioeconomic status and obesity prevalence varied substantially across racial and ethnic subpopulations 42418390Jul. In people with HIV, switching to integrase strand-transfer inhibitors was linked to weight gain and increased risk of obesity, diabetes, hypertension, and major adverse cardiovascular events 41911941Mar. Environmental exposures including particulate matter and traffic noise demonstrated associations with obesity and related metabolic measures in a population-based German cohort of 174,955 participants 41748006Feb.

Behavioral and lifestyle interventions, as well as mechanistic investigations, have explored additional approaches to obesity prevention and management. Randomized and qualitative studies evaluated cooking-skills training in young adults with intellectual disability, a population with high obesity prevalence 42288222Jun, and web-based family lifestyle programs for school-aged children with overweight or obesity 42086257May. Mechanistic investigations examined how traditional Chinese medicine preparations influence lipid metabolism and gut microbiota composition in obesity and metabolic dysfunction–associated steatotic liver disease 42445565Jul. Longitudinal evidence spanning 27 years showed that childhood physical fitness independently predicts adult obesity and metabolic syndrome beyond traditional cardiovascular risk factors 39993170Feb.

What Changes, What Holds

1. Real-world tirzepatide and dual agonist use achieves sustained weight reduction exceeding 17% at one year
REINFORCES tirzepatide produces mean weight loss of −13.5% at six months and −17.4% at twelve months in a real-world UK cohort, with 89.9% achieving at least 5% reduction within six months 42560020Aug. This validates the GLP-1 receptor and GIP/GLP-1 co-agonism pathways the Overview identifies as central to obesity biology, confirming their therapeutic significance at scale and raising questions about durability after drug discontinuation.

2. Prepregnancy obesity's association with preeclampsia and eclampsia varies substantially across racial and ethnic groups
NEW DIRECTION Prepregnancy obesity raises preeclampsia and eclampsia risk with substantial variation by race and ethnicity, particularly affecting Black, Hispanic, and American Indian/Alaska Native populations 42294754Jun. The Overview identifies pregnancy-related complications as obesity-associated harms but does not address how risk stratifies demographically. Concurrent surgical outcomes studies reinforce the broader principle that obesity affects multiple organ systems; the novel finding is that obesity-related pregnancy outcomes require demographic specificity in clinical risk prediction and management.

3. Socioeconomic status and environmental exposures shape obesity's epidemiology distinctly across demographic groups
NEW DIRECTION Socioeconomic status associates with obesity differently across racial and ethnic groups 42418390Jul, while environmental exposures including particulate matter and traffic noise link to obesity and metabolic measures in a large population-based cohort 41748006Feb. The Overview identifies diet and physical activity as obesity factors but does not address how social determinants or environmental hazards shape disease epidemiology. These findings suggest obesity's epidemiology is shaped by structural and environmental factors beyond individual behavioral choices.

4. Childhood physical fitness independently predicts adult obesity and metabolic syndrome over decades
NEW DIRECTION Childhood physical fitness independently predicts adult obesity and metabolic syndrome across a 27-year span, beyond conventional cardiovascular risk factors 39993170Feb. The Overview describes obesity as shaped by diet, physical activity, and biological pathways but does not establish long-term predictors from childhood. This longitudinal evidence suggests early-life fitness interventions may have durable effects, though whether this association is causal or mediated by persistent behavioral and metabolic factors remains unsettled.

Overview update candidates: real-world tirzepatide efficacy data; racial/ethnic disparities in obstetric complications; environmental and socioeconomic determinants of obesity prevalence; childhood physical fitness as a longitudinal predictor.